Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer.
[esophageal carcinoma]
Patients
with
esophageal
carcinoma
(
EC
)
who
are
treated
with
definitive
chemoradiotherapy
(
bimodality
therapy
[
BMT
]
)
experience
frequent
relapses
.
In
a
large
cohort
,
we
assessed
the
timing
,
frequency
,
and
types
of
relapses
during
an
aggressive
surveillance
program
and
the
value
of
the
salvage
strategies
.
Patients
with
EC
(
N
=
276
)
who
received
BMT
were
analyzed
.
Patients
who
had
surgery
within
6
months
of
chemoradiotherapy
were
excluded
to
reduce
bias
.
We
focused
on
local
relapse
(
LR
)
and
distant
metastases
(
DM
)
and
the
salvage
treatment
of
patients
with
LR
only
.
Standard
statistical
methods
were
applied
.
The
median
follow-up
time
was
54
.
3
months
(
95
%
CI
,
48
.
4
to
62
.
4
)
.
First
relapses
included
LR
only
in
23
.
2
%
(
n
=
64
)
,
DM
with
or
without
LR
in
43
.
5
%
(
n
=
120
)
,
and
no
relapses
in
33
.
3
%
(
n
=
92
)
of
patients
.
Final
relapses
included
no
relapses
in
33
.
3
%
,
LR
only
in
14
.
5
%
,
DM
only
in
15
.
9
%
,
and
DM
plus
LR
in
36
.
2
%
of
patients
.
Ninety
-
one
percent
of
LRs
occurred
within
2
years
and
98
%
occurred
within
3
years
of
BMT
.
Twenty
-
three
(
36
%
)
of
64
patients
with
LR
only
underwent
salvage
surgery
,
and
their
median
overall
survival
was
58
.
6
months
(
95
%
CI
,
28
.
8
to
not
reached
)
compared
with
those
patients
with
LR
only
who
were
unable
to
undergo
surgery
(
9
.
5
months
;
95
%
CI
,
7
.
8
to
13
.
3
)
.
Unlike
in
patients
undergoing
trimodality
therapy
,
for
whom
surveillance
/
salvage
treatment
plays
a
lesser
role
,
(
1
)
in
the
BMT
population
,
approximately
8
%
of
all
patients
(
or
36
%
of
patients
with
LR
only
)
with
LRs
occurring
more
than
6
months
after
chemoradiotherapy
can
undergo
salvage
treatment
,
and
their
survival
is
excellent
.
Our
data
support
vigilant
surveillance
,
at
least
in
the
first
24
months
after
chemotherapy
,
in
these
patients
.
Diseases
Validation
Diseases presenting
"large cohort"
symptom
adrenal incidentaloma
adrenomyeloneuropathy
cadasil
child syndrome
congenital diaphragmatic hernia
cushing syndrome
cystinuria
erdheim-chester disease
esophageal adenocarcinoma
esophageal carcinoma
esophageal squamous cell carcinoma
fabry disease
familial mediterranean fever
inclusion body myositis
junctional epidermolysis bullosa
kabuki syndrome
krabbe disease
oligodontia
pendred syndrome
phenylketonuria
thoracic outlet syndrome
waldenström macroglobulinemia
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom